Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel)
NCT01718964 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-10-30
Summary
To investigate the effects of cortisol on heroin craving and stress reaction in heroin addicted subjects Randomized, double-blind, placebo-controlled, cross-over, single administration of study medication Study hypothesis:Cortisol has an inhibiting effect on heroin craving and stress reactivity in opioid dependent subjects.
Conditions
- Opioid Dependence
Interventions
- DRUG
-
Cortisol 20 mg
- DRUG
-
Mannitol
Mannitol used as placebo
Sponsors & Collaborators
-
Prof. Dominique de Quervain, MD
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging CRF X NOP Interactions in CUD
NCT05008146 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Individualized Neuromodulation of Craving Control for Meth Use Disorders
NCT06695637 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals
NCT01963091 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-blockade Effects on Memory for Cocaine Craving
NCT00830362 ·Status: COMPLETED ·Phase: PHASE2
-
Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates
NCT00865332 ·Status: WITHDRAWN
-
Brain Dopaminergic Signaling in Opioid Use Disorders
NCT03190954 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
CRF - Nociceptin Receptor Interactions
NCT03302416 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Propranolol on Responses to Drug-Related Imagery Scripts
NCT00688805 ·Status: TERMINATED ·Phase: PHASE1
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Cocaine Use and Withdrawal on Sleep
NCT07119567 ·Status: RECRUITING
-
Effects of Carvedilol on Cocaine Use in Humans - 11
NCT00000294 ·Status: COMPLETED ·Phase: PHASE2
-
Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans
NCT01605539 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Networks and Addiction Susceptibility
NCT01924468 ·Status: COMPLETED ·Phase: PHASE1
-
Orexin s Role in the Neurobiology of Substance Use Disorder
NCT05630781 ·Status: RECRUITING ·Phase: NA
-
Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
NCT02742532 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Use Disorder and Cortical Dopamine
NCT03349606 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Stress, Distress Intolerance, and Drug Dependence
NCT00430482 ·Status: COMPLETED ·Phase: NA
-
IV Cocaine Abuse: A Laboratory Model - 3
NCT00000214 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Donepezil for Treatment of Cocaine Dependence
NCT00467389 ·Status: COMPLETED ·Phase: PHASE2
-
Ondansetron for the Treatment of Methamphetamine Dependence - 1
NCT00040053 ·Status: COMPLETED ·Phase: PHASE2
-
New Medication Treatment for Stimulant Dependence
NCT00689572 ·Status: COMPLETED ·Phase: PHASE2
-
Tyrosine for Methamphetamine Dependence - 1
NCT00000322 ·Status: COMPLETED ·Phase: PHASE2
-
Developing a Clinical Outcome Assessment for Opioid Craving
NCT05109429 ·Status: RECRUITING ·Phase: NA
-
Progesterone for the Treatment of Cocaine Dependence - 1
NCT00218257 ·Status: COMPLETED ·Phase: NA